Locoregional Therapy for the Primary Tumour in Women with a De Novo Diagnosis of Metastatic Breast Cancer

[1] Bhoo-Pathy N(2019)Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study JAMA Oncol 5 1749-1768

[2] Verkooijen HM(2015)Trends in presentation, management and survival of patients with de novo metastatic breast cancer in a Southeast Asian setting Sci Rep 5 16252-1659

[3] Tan EY(2018)Change in survival in metastatic breast cancer with treatment advances: meta-analysis and systematic review JNCI Cancer Spectr 2 pky062-653

[4] Miao H(2001)Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer N Engl J Med 345 1655-738

[5] Taib NA(2019)Surgery and survival in patients with stage IV breast cancer Breast J 25 644-3395

[6] Brand JS(2008)Association of surgery with improved survival in stage IV breast cancer patients Ann Surg 247 732-626

[7] Caswell-Jin JL(2008)Matched pair analyses of stage IV breast cancer with or without resection of primary breast site Ann Surg Oncol 15 3384-544

[8] Plevritis SK(2002)Does aggressive local therapy improve survival in metastatic breast cancer? Surgery. 132 620-112

[9] Tian L(2019)Surgical resection of the primary tumor in women with de novo stage IV breast cancer: contemporary practice patterns and survival analysis Ann Surg 269 537-1233

[10] Cadham CJ(2019)Locoregional surgical treatment improves the prognosis in primary metastatic breast cancer patients with a single distant metastasis except for brain metastasis Breast. 45 104-554

[1] Bhoo-Pathy N(2019)Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study JAMA Oncol 5 1749-1768

[2] Verkooijen HM(2015)Trends in presentation, management and survival of patients with de novo metastatic breast cancer in a Southeast Asian setting Sci Rep 5 16252-1659

[3] Tan EY(2018)Change in survival in metastatic breast cancer with treatment advances: meta-analysis and systematic review JNCI Cancer Spectr 2 pky062-653

[4] Miao H(2001)Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer N Engl J Med 345 1655-738

[5] Taib NA(2019)Surgery and survival in patients with stage IV breast cancer Breast J 25 644-3395

[6] Brand JS(2008)Association of surgery with improved survival in stage IV breast cancer patients Ann Surg 247 732-626

[7] Caswell-Jin JL(2008)Matched pair analyses of stage IV breast cancer with or without resection of primary breast site Ann Surg Oncol 15 3384-544

[8] Plevritis SK(2002)Does aggressive local therapy improve survival in metastatic breast cancer? Surgery. 132 620-112

[9] Tian L(2019)Surgical resection of the primary tumor in women with de novo stage IV breast cancer: contemporary practice patterns and survival analysis Ann Surg 269 537-1233

[10] Cadham CJ(2019)Locoregional surgical treatment improves the prognosis in primary metastatic breast cancer patients with a single distant metastasis except for brain metastasis Breast. 45 104-554